Russian Investors interested in European Healthcare and Pharma business
Pharma business development in Russia. Russian investors are interested in West-European Pharma targ(firmenpresse) - More and more Russian investors and Pharma companies are interested in West- European healthcare and Pharma / OTC targets. Nowadays the CIS and CEE Pharma markets develop very well, mostly above 15-17%. However the markets are still dominated by more than 80% imported products from West-Europe, Asia and the US. Will this change? What will change?
We at Chameleon Pharma Consulting notice that more and more Russian, Ukrainian, Polish and Kazak investors and Pharma cooperations are interested to acquire healthcare or pharmaceutical products and companies in Western Europe. Some players like the Slovenian KRKA Group have already made a move towards “west” some years ago. They bought the German Pharma company TAD in the North of the country. Others Russian investors are currently on “a Pharma & Medical company target shopping tour” in Europe. However Russian investors seam to be “slow movers” to invest into Medical or Pharma companies in Europe. This may happen due to the lack of market knowledge or other reasons. “Howerver such investments in Europe could definitely bring innovative products and techniques to the Russian healthcare market and investors could benefit from long term stable profits”, say Reiner Christensen, the CEO of Chameleon Pharma Consulting. “We, Chameleon Pharma Consulting, had many interesting discussions with Russian investors during last months, but Russian players need to be quicker in the due diligence execution”, says Andreas Masel, the Pharma veteran of Chameleon Pharma Consulting. US and Asian investors seem to be faster so far to decide on innovative healthcare investments in Europe and thus earn the advantages from these smart steps.
Andreas Masel adds, “I would recommend Russian investors, interested in Pharma and Medical assets, balancing their portfolio and acquiring more targets in West- Europe. This could also bring good technologies to the CIS & CEE markets.”
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Chameleon Pharma Consulting is the healthcare and Pharma consulting expert for the CIS and Eastern European markets. Except for acquisition of targets and due diligence consulting, a part of the major business of Chameleon Pharma Consulting is the search for dynamic and highly-productive Healthcare sale and marketing partners on the CEE & GUS markets.
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
Germany
Tel: +49 30 648 35 163
Fax: +49 30 648 32 008
service(at)chameleon-pharma.com
www.chameleon-pharma.com
Ansprechpartner: Olga Kiefer
Tel: 030 648 35 164
E-mail: olki(at)chameleon-pharma.com
Datum: 13.03.2012 - 16:57 Uhr
Sprache: Deutsch
News-ID 124351
Anzahl Zeichen: 1962
contact information:
Contact person: Olga Kiefer
Town:
Berlin
Phone: 030 648 25 164
Kategorie:
Healthcare & Medical
Typ of Press Release: Finanzinformation
type of sending: Veröffentlichung
Diese Pressemitteilung wurde bisher 663 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Russian Investors interested in European Healthcare and Pharma business"
steht unter der journalistisch-redaktionellen Verantwortung von
Chameleon Pharma Consulting (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
